Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANGIOCOMB for Pediatric Brain Stem Tumors
NCT01756989Phase 2Completed
- Sponsor
- Helsinki University Hospital
- Start
- Jan 2005
- Primary completion
- Dec 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of thalidomide, celecoxib, etoposide in brainstem glioma, thalamic tumor, sponsored by Helsinki University Hospital. Started Jan 2005; status: completed.
02
Drugs
thalidomidecelecoxibetoposide
03
Conditions
brainstem gliomathalamic tumor
Beyond the preview
Go deeper on NCT01756989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01756989.